Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Karyopharm Therapeutics

Karyopharm Therapeutics reported $318.54M in Current Assets for its fiscal quarter ending in March of 2023.

Current Assets Change
Abbott ABT:US USD 24.38B 847M
Amgen AMGN:US USD 44.7B 22.52B
AstraZeneca AZN:LN USD 22.27B 327M
Avrobio Inc AVRO:US USD 77.25M 22.71M
Eli Lilly LLY:US USD 20.81B 2.78B
Enanta Pharmaceuticals ENTA:US USD 271.14M 12.57M
GlaxoSmithKline GSK:LN GBP 19.72B 1.05B
Incyte Corp INCY:US USD 3.97B 121.22M
J&J JNJ:US USD 64.39B 9.09B
Karyopharm Therapeutics KPTI:US USD 318.54M 37.93M
MacroGenics MGNX:US USD 288.94M 66.76M
Mirati Therapeutics MRTX:US USD 939.35M 169.61M
Nektar Therapeutics NKTR:US USD 491.07M 54.9M
Novartis NOVN:VX USD 32.11B 4.8B
Novartis NVS:US USD 32.11B 4.8B
Regeneron Pharmaceuticals REGN:US USD 16.91B 1.03B
Roche Holding ROG:VX 33.82B 3.5B
Sangamo BioSciences SGMO:US USD 227.09M 73.24M
Takeda 4502:JP JPY 2.4T 197.99B
TG Therapeutics TGTX:US USD 184.78M 16.51M
Ultragenyx Pharmaceutical RARE:US USD 766.34M 117.56M
Xencor XNCR:US USD 629.98M 45.37M